Articles Related to Spinal cord
Review Article: Managing Spinal Cord Injury on Anesthesiologists’ Perspective
Spinal cord injury (SCI) is trauma to the area of the vertebrae resulting in spinal cord lesions resulting in neurological
disorders, depending on the location of the spinal nerve damage and the injured nerve tissue. The symptoms of SCI can range from
pain and paralysis to incontinence. SCI due to trauma is estimated to occur in 30-40 per million population per year, and about 8,000-
10,000 sufferers each year; generally, occurs in adolescents and young adults. Although the annual incidence of events is relatively low,
the cost of care and rehabilitation for spinal cord injuries is very high, at around US $ 53,000 / patient.
Retrospective Analysis of 185 Occurrences of Clinical Neurological Signs in 181 South American Camelids
Medical records of each occurrence of neurologic signs in 181 South American Camelids admitted on 185 occasions (90 alpacas and 95 llamas) were evaluated. Age ranged from 0 days to 20 years, but 70.5% of cases were ≥ 1 year old. Specific clinical diagnosis was achieved by cerebrospinal fluid analysis (CSF), radiographs, computed tomography, laboratory testing, or necropsy in 74% of cases. 54% of cases survived; 46% of cases died or were euthanized. The most common diagnosis (31%) was parasitic myelopathy/encephalopathy (PME). CSF eosinophilia ≥10% was found in 85% of parasitic spinal migrations but only in 55% of intracranial migrations, and 73% had increased protein in CSF. There was a seasonal bias for PME with 79% of cases occurring between October and March. Survival of PME cases was 77% for spinal migration but only 7% when intracranial migration occurred. The most common diagnoses, excluding PME, were infectious disease (15%) and trauma (12%). Most trauma cases involved the cervical spine of which 50% survived.
Spinal Cord Compression Due to Extramedullary Hematopoiesis in a 27-Year-Old Man with Beta Thalassemia Intermedia: A Case Report
Extramedullary hematopoiesis (EMH) occurs in approximately 15% of cases of thalassemia. Paraspinal mass of extramedullary hematopoiesis are a rare compensatory process in intermediate and severe thalassemia.
Mesenchymal Stem Cells in the Treatment of Patients with Chronic Spinal Cord Injury (ASIA A) with Residual Electrophysiological Function
Bone-marrow derived mesenchymal stem cells (MSC) represent an experimental form of therapy in the treatment of chronic spinal cord injury (SCI), up to two years after trauma.
Vertebro-Spinal Hydatidosis: Case Report
Hydatid disease is caused by the larval form of parasitic tapeworm; Echinococcus granulosus. Primary spinal hydatid disease is rare. Primary bone localization is rare and it accounts between 0.5% and 4%. Spinal localization accounts for less than 1%. The infection may be misdiagnosed initially.
Vocational Decision-Making and Rehabilitation Following Paediatric Traumatic Spinal Cord Injury: An Illustrative Case Study Analysis
Within traumatic-injury populations, adjustment following the suffering of a permanent impairment such as a traumatic Spinal Cord Injury (tSCI) follows quite a different path (and has quite different longer term participation outcomes) when the individual involved is a child or adolescent, and not an adult.
Editorial Board Members Related to Spinal cord
Inbo Han
Associate professor
Department of Neurosurgery
CHA University
South Korea
Department of Neurosurgery
CHA University
South Korea
YUNBO LI
Professor
Department of Pharmacology
Campbell University School of Osteopathic Medicine
United States
Department of Pharmacology
Campbell University School of Osteopathic Medicine
United States
Gang Chen
Professor
Jiangsu Key Laboratory of Neuroregeneration
Nantong University
China
Jiangsu Key Laboratory of Neuroregeneration
Nantong University
China
Xiaohong Kong
Professor
Medical & Molecular Virology Laboratory
Nankai University
China
Medical & Molecular Virology Laboratory
Nankai University
China
Li Yao
Assistant Professor
Department of Biological Sciences
Wichita State University
United States
Department of Biological Sciences
Wichita State University
United States
Michael P. Namaka
Associate Professor
Faculty of Pharmacy and Medicine
University of Manitoba
Canada
Faculty of Pharmacy and Medicine
University of Manitoba
Canada
Avner Meoded
Neuroimaging Research Fellow
NIH/NINDS
United States
NIH/NINDS
United States